This month in investigative urology: adoptive immunotherapy of genitourinary tumors with interleukin-2.
Linehan
W M
WM
Urologic Oncology Section, National Cancer Institute, Bethesda, Maryland 20892.
D000818:Animals; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D051379:Mice; D014565:Urogenital Neoplasms / Q000628:therapy*
D007376:Interleukin-2